Quantcast Elan's AD Drug Down, Not Out: J&J Pledges $1.5B In Venture - Congoo
 
 
Log In
Elan's AD Drug Down, Not Out: J&J Pledges $1.5B in Venture
Have an interest in this Story?
Sign Up for Real-Time email updates
BioWorld  | July 04, 2009

Analyst: 'They Have Rolled the Dice' By Catherine Hollingsworth Staff Writer Johnson & Johnson plans to make a whopping $1.5 billion investment in Elan Corp. plc in exchange for a stake in Dublin-based Elan, in a deal that will transfer key Alzheimer's programs, including Phase III bapineuzumab, to ...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Rama Sethu Ranga Nathan Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry
Niladri Roy Niladri Roy
Manager-International Marketing
Computer Services

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.